CPNG A Material Weakness Vanished - But Nobody Actually Fixed Anything

A Genuinely Clean Operating Quarter, With One Disclosure That Doesn't Add Up

Coupang's first quarter of 2025 is the cleanest quarter this site has covered in a while: net income of $114 million, reversing Q1 2024's $24 million loss, on Adjusted EBITDA^» of $382 million, up 36% from $281 million a year ago. Every headline metric moved the right direction - revenue, gross profit, operating income, segment margins, free cash flow - and none of it depends on a one-time gain the way Q4 2024's $175 million insurance settlement did. If the quarter ended at the income statement, this would be a short, boring, good-news post.

It doesn't end there, because of a sentence buried in this filing's internal-controls disclosure. Last quarter's 10-K disclosed, for the first time, that Farfetch Limited's own pre-acquisition material weakness - covering IT and business-process controls in the New Guards business - "was not fully remediated as of December 31, 2024." This filing doesn't say it got fixed. It says something stranger: as a result of "ongoing business restructuring and divestiture activities related to the New Guards business," Coupang now believes "it is not reasonably possible for the material weakness previously disclosed by Farfetch Limited to result in a material misstatement" - so the same combination of deficiencies "is not a material weakness." The controls didn't improve. The business they sit inside got smaller. See Beyond the Usual below for what that restructuring actually involved.

The Prescription

Coupang should keep disclosing the New Guards material weakness as an open item until it can point to something a reader would recognize as remediation - a specific control implemented, a specific test passed - rather than letting shrinking the underlying business do the job instead. A reader who skims quarter-over-quarter filings and sees "material weakness" replaced by silence will reasonably conclude the problem was fixed. It wasn't; the exposure was divested down to a size where the accounting rules no longer require flagging it. Those are different facts, and only one of them is actually good news.

What it should stop doing: letting the Greenoaks/Neil Mehta related-party structure resolve itself through a private transaction rather than addressing the governance question directly. This site flagged the conflict when the Farfetch deal was first announced - a sitting board member's own firm co-investing in an entity his board just approved acquiring. The exit finally happened this quarter (see Beyond the Usual), and it's a clean resolution on the numbers. But nothing in three years of filings ever explained why the structure was set up that way in the first place, or what independent process (if any) governed Coupang's side of negotiating Greenoaks' buyout. A related-party transaction closing quietly isn't the same as the related-party question being answered.

Key Financial Metrics

Q1 2025 vs. Q1 2024 - reported in USD, figures from this 10-Q's condensed consolidated financial statements

Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this Form 10-Q's condensed consolidated financial statements and MD&A tables, covering the quarter ended March 31, 2025.

Metric	Q1 2025	Q1 2024	YoY
Total net revenues	$7,908M	$7,114M	✅ +11%
Gross profit	$2,316M	$1,929M	✅ +20%, margin 29.3% vs 27.1%
Operating income	$154M	$40M	✅ +285%
Adjusted EBITDA»	$382M	$281M	✅ +36%, margin 4.8% vs 3.9%
Income before income taxes	$216M	$59M	✅ +266%
Income tax expense	$102M	$83M	⚠️ +23%, effective rate 47.2% vs 140.7%
Net income (consolidated)	$114M	$(24)M	✅ reversed to a profit
Net income attributable to Coupang stockholders	$107M	$5M	✅ up sharply
Net cash provided by operating activities	$354M	$212M	✅ +67%
Free cash flow»	$116M	$107M	✅ +8%
Cash & cash equivalents (period end)	$6,113M	-	vs $5,879M at Dec 2024

Balance sheet metric	Mar 2025	Dec 2024	Change
Total assets	$15,986M	$15,344M	✅ +4.2%
Total liabilities	$11,588M	$11,167M	⚠️ +3.8%
Total equity	$4,374M	$4,102M	✅ +6.6%
Redeemable noncontrolling interest	$24M	$75M	✅ -68%, ahead of Greenoaks' full exit - see below

Total short- and long-term debt (short-term borrowings, current portion of long-term debt, and long-term debt) rose modestly to $1.558 billion at quarter-end from $1.533 billion at year-end - a smaller increase than any quarter since the Farfetch acquisition. Capital expenditure (purchases of property and equipment) more than doubled to $239 million from $107 million a year ago, yet free cash flow still grew, because operating cash flow more than covered the increase. Long-term operating lease obligations climbed 17.4% to $2.078 billion from $1.770 billion, consistent with continued fulfillment-center expansion.

The effective tax rate of 47.2% (vs. 140.7% a year ago, when a small pre-tax profit was swamped by a mostly fixed tax bill) still runs well above the U.S. statutory rate - a pattern this site has tracked since the KFTC fine's accrual made a large slice of Coupang's tax expense structurally non-deductible; nothing in this filing suggests that's changed.

Segment Performance: Product Commerce vs. Developing Offerings

Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, fintech, and, since Q1 2024, Farfetch).

Metric	Product Commerce Q1 2025	Product Commerce Q1 2024	Developing Offerings Q1 2025	Developing Offerings Q1 2024
Net revenues	$6,870M	$6,494M	$1,038M	$620M
Revenue growth	✅ +5.8%	—	✅ +67%	—
Segment Adjusted EBITDA	✅ $550M (margin 8.0%)	$467M (margin 7.2%)	⚠️ $(168)M (margin -16.2%)	$(186)M (margin -30.0%)

Product Commerce posted an 8.0% segment margin - its second-best quarter this site has tracked, just behind Q2 2024's record 8.2% and ahead of every other quarter across 2024, confirming the segment has settled into a genuine high-7s-to-8% range rather than Q2 2024 being a one-off spike. Revenue growth of 5.8% is Product Commerce's slowest of the five quarters this site has now tracked back to Q1 2024, a deceleration worth watching given the segment still carries essentially the entire company's profitability.

Developing Offerings' loss narrowed 10% YoY to $(168) million even as revenue grew 67% - both effects mostly Farfetch, which is now in its second full year of consolidation and no longer distorts YoY comparisons the way Q1 2024's partial two-month stub did. The margin improvement (from -30.0% to -16.2%) is the clearest sign yet that Farfetch's drag on the segment is easing, consistent with FY2024's full-year figure showing Farfetch's own Adjusted EBITDA loss at just $34 million against a much larger GAAP net loss.

Key Operational Metrics

Quarter	Product Commerce Active Customers	Net revenues per Product Commerce Active Customer
Mar 2024	21.5M	$302
Jun 2024	21.7M	$296
Sep 2024	22.5M	$307
Dec 2024	22.8M	$302
Mar 2025	23.4M	$294

Product Commerce Active Customers^» grew 9% YoY to a new high of 23.4 million, adding 0.6 million sequentially - a reacceleration from Q4 2024's smallest add of the year. Revenue per customer dipped to $294, its lowest level in the five quarters this site has tracked, down 3% YoY (though up 6% on a constant-currency basis - the Korean won weakened enough this quarter to erase most of the underlying per-customer revenue growth). Read together: the customer base is growing faster than at any point in the past year, but nominal spend per customer is being held down by currency, not by weaker underlying engagement.

"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter this site has tracked.

Beyond the Usual

A material weakness disappeared through restructuring, not remediation

Last quarter's 10-K disclosed that a material weakness Farfetch Limited itself identified for 2022 - covering IT and business-process controls in the New Guards business - "was not fully remediated as of December 31, 2024." This filing does not describe remediation. It states that "as a result of the ongoing business restructuring and divestiture activities related to the New Guards business, and upon further review and assessment of the impact of Farfetch on the Company's internal control over financial reporting during the quarter ended March 31, 2025, we now believe that it is not reasonably possible for the material weakness previously disclosed by Farfetch Limited to result in a material misstatement such that the combination of deficiencies previously identified is not a material weakness." In plain terms: the same unfixed IT and process gaps still exist, but the New Guards business has been restructured and partly divested (see the Palm Angels transaction below) to a scale where those gaps can no longer plausibly cause a material misstatement of Coupang's consolidated numbers. A reader tracking this disclosure across two filings could easily read "material weakness" quietly dropping out of the text as good news. It isn't remediation - it's exposure reduction through shrinkage, and no target date or description of an actual fix has ever been given.

The KFTC matter moved from investigation to formal criminal indictment

The KFTC litigation tracked across prior filings crossed a real threshold this quarter. As previously disclosed, hearings of the administrative appeal were held in November 2024 and March 2025; this filing adds that a third hearing is now scheduled for June 2025, with the underlying product-rankings finding still unresolved on appeal. Separately, and more seriously: in response to the KFTC's original criminal referral, the Seoul Eastern District Prosecutors' Office had opened a criminal investigation into Coupang Corp. and CPLB in November 2024; as a subsequent event, that office issued a formal indictment dated May 1, 2025, on the same underlying facts as the administrative case. The stated maximum penalty under the indictment is a fine of approximately $200,000 - trivial in dollar terms next to the $121 million administrative fine already being paid in installments - but Coupang itself frames this as "the first instance globally of a prosecution related to the sufficiency of product ranking disclosure," meaning the legal precedent at stake here is bigger than the number attached to it. Coupang says it has "substantial defenses" and will defend against the charges in court. The KFTC's separate, broader investigation into "other matters" related to the same alleged violations remains open with no estimate of additional exposure - identical unresolved-scope language to every prior filing this site has tracked.

Greenoaks Capital Partners fully exited its Farfetch-vehicle stake, closing a governance thread flagged since the acquisition

Three straight quarterly filings once dropped the naming of Greenoaks Capital Partners, LLC as the 19.9% co-investor in Surpique LP, the vehicle used to acquire Farfetch, before last quarter's 10-K restored full disclosure of both the firm and Neil Mehta - the Coupang board member who has served as a Managing Partner of Greenoaks since April 2012. This filing discloses the resolution as a subsequent event: on April 7, 2025, Coupang entered a Master Transaction Agreement with Greenoaks to acquire, indirectly, all of Greenoaks' limited-partner interest in Surpique LP, paying $14 million in cash plus 5,465,099 shares of Class A common stock. The redeemable noncontrolling interest on Coupang's balance sheet - which carried Greenoaks' stake at $100 million estimated redemption value as of year-end - had already fallen to $24 million by this quarter's own balance sheet date, ahead of the full buyout closing weeks later. This is a clean outcome: the related-party structure this site flagged as a governance concern when the Farfetch deal was first announced no longer exists. But three years passed between that original disclosure and this exit, during which the arrangement went through phases of both full disclosure and near-total silence (see above) - worth remembering the next time a related-party co-investment shows up in a Coupang filing.

A separately-filed derivative lawsuit and two Board demands add to a growing litigation list around the same underlying allegations

The Choi v. Coupang securities class action tracked across every prior filing remains open with no lead plaintiff named. A fifth stockholder derivative action was filed in Delaware Chancery Court in March 2025, joining the December 2024 Delaware filing and three earlier Southern District of New York suits - none of these actions have yet produced a lead plaintiff, a settlement, or a dismissal. This filing also discloses that Coupang received Board demands in both February and March 2025 (last quarter's 10-K disclosed only the February demands as a subsequent event), each alleging claims similar to the class and derivative actions and demanding the Board pursue civil action against certain current and former directors and officers. Those demands remain before the Board for evaluation, with no update on timeline or outcome.

Buried in the segment reconciliation table is a swing from $(58) million of "acquisition and restructuring related gains and (losses), net" in Q1 2024 to a $15 million gain this quarter - the clearest numerical trace of the Farfetch integration work moving from a cost center to a modest net positive, consistent with the material-weakness disclosure above describing active restructuring and divestiture inside New Guards.

Coupang's Farfetch-restructuring activity this quarter included a small, almost paradoxical transaction: in February 2025, Coupang acquired the remaining 40% of Palm Angels (an apparel brand) it didn't already own through New Guards Group Holdings S.p.A. - and then, in the same move, sold the rights to the Palm Angels brand itself as part of the broader New Guards restructuring. Buying out a minority stake and divesting the underlying asset in the same breath is an unusual sequence, and it's exactly the kind of activity behind the material-weakness disappearance flagged above - New Guards is visibly being reshaped and shrunk, not stabilized.

Coupang entered a new unconditional purchase obligation of $328 million with remaining payments through 2030 during the quarter - primarily technology services, fulfillment-center construction, and content/software licensing commitments, per the filing's own description of this category. None of it shows up on the balance sheet today, but it's a real multi-year commitment layered on top of whatever was already disclosed at year-end.

As a subsequent event, Coupang's Board authorized a $1 billion stock repurchase program in May 2025 - the company's first standing buyback authorization since an April 2024 one-off private-transaction repurchase of 10 million shares. The program has no expiration date and no obligation to repurchase any specific amount, so it's a capital-allocation option management has given itself rather than a commitment - worth watching in future quarters for whether it's actually used.

Target Valuation Range

EV $35.1 billion, ~1.13x EV/Revenue. Bottom line: Coupang's EV/Revenue multiple sits at roughly 1.13x trailing-twelve-months - essentially flat with Q4 2024's ~1.16x - meaning the market gave this quarter's genuinely strong operating numbers almost no re-rating credit.

Coupang closed Q1 2025 (March 31, 2025) at $21.93, essentially flat with $21.98 at Q4 2024's close and up 23.3% from $17.79 a year earlier. Within the quarter the stock touched a high of $23.70 in February before slipping back - a modest round-trip, nothing like the 15% post-October pullback flagged last quarter. With 1,649 million Class A shares and 158 million Class B shares outstanding (1,807 million total) as of March 31, 2025, that implies a market capitalization of approximately $39.6 billion, essentially unchanged from Q4's $39.6 billion on the flat share price.

Using cash and cash equivalents of $6.113 billion against total debt of approximately $1.558 billion, net cash comes to roughly $4.555 billion, putting enterprise value at approximately $35.1 billion - again essentially flat with Q4.

Market cap → enterprise value	Q1 2025
Share price (period-end)	$21.93
Shares outstanding (Class A + B)	1,807 million
Market capitalization	$39.6 billion
Net cash (cash & equivalents less total debt)	$4.555 billion
Enterprise value	$35.1 billion

EV/Revenue sanity check	Q4 2024	Q1 2025	Change
Enterprise value	$35.1 billion	$35.1 billion	down
EV/Revenue	1.16x	1.13x	down

• EV/Revenue^» using trailing-twelve-months revenue (FY2024's $30.268 billion minus Q1 2024's $7.114 billion plus this quarter's $7.908 billion, or $31.062 billion): ~1.13x, down slightly from Q4's ~1.16x - the multiple has now sat inside a tight 1.1x-1.2x band for two straight quarters after the sharper swings of 2023-2024.

DCF and reverse DCF (illustrative only): seventeen quarters of public-company data now cover Q3 2021 through Q1 2025. Checking this year against FY2024's base case for 2025:

Scenario	Assumption / outcome
Current (period-end close)	Actual EV/Revenue this quarter, for reference: 1.13x
FY2024 base case	The FY2024 base case called for the KFTC appeal to continue without a near-term ruling either way, the material weakness to get substantively remediated during 2025, Product Commerce's margin to hold in the 7-8% range, and the multiple to recover toward 1.25-1.4x. Three of four came in differently than framed: the KFTC appeal didn't stay static - it escalated to a formal indictment, a more serious development than a stalled appeal. The material weakness didn't get remediated in the sense the base case meant (a fix); it disappeared through business shrinkage instead, a technically-true-but-hollow version of the base case's language. Product Commerce's margin did hold inside (in fact above) the 7-8% range at 8.0%. The multiple did not recover - it stayed compressed at ~1.13x, below even the bear case's implied floor from last quarter.
Bear case for next quarter	Bear case for next quarter: the June 2025 KFTC hearing or the criminal indictment produces an adverse development, Product Commerce's growth deceleration (5.8% this quarter, the slowest of the past four) continues into a genuine slowdown, and the multiple stays compressed below 1.15x on accumulating governance and regulatory overhang.
Base case for next quarter	Base case for next quarter: the KFTC matters continue without near-term resolution either way, Product Commerce's margin holds around 8%, the newly authorized buyback goes unused or is used modestly, and the multiple stays roughly flat in the 1.1x-1.2x band.
Bull case for next quarter	Bull case for next quarter: the KFTC criminal matter resolves favorably or with minimal penalty given the small statutory maximum, Coupang begins executing meaningfully against the $1 billion buyback authorization, Developing Offerings' losses keep narrowing toward breakeven, and the multiple re-rates back toward the 1.25x+ range last seen briefly in Q3 2024.

---